Effect of Recombinant Human Interferon α-2b Spray on Herpangina
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, open，randomized controlled trial aiming to evaluate the effectiveness
of recombinant human interferon α-2b spray compared with ribavirin treatment on pediatric
patients with herpangina.
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital of Fudan University
Collaborators:
Anhui Provincial Children's Hospital Changhai Hospital Children's Hospital of Chongqing Medical University Children's Hospital of Kaifeng City Hunan Children's Hospital Qilu Children's Hospital of Shandong University Shenzhen Children's Hospital Tianjin Sinobioway Biomedicine Co.Ltd. Yuying Children's Hospital of Wenzhou Medical University Zunyi Medical College